These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 23144327)

  • 1. Neurohormonal axis in patients with pulmonary arterial hypertension: friend or foe?
    de Man FS; Handoko ML; Guignabert C; Bogaard HJ; Vonk-Noordegraaf A
    Am J Respir Crit Care Med; 2013 Jan; 187(1):14-9. PubMed ID: 23144327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurohormonal activation and pharmacological inhibition in pulmonary arterial hypertension and related right ventricular failure.
    Ameri P; Bertero E; Meliota G; Cheli M; Canepa M; Brunelli C; Balbi M
    Heart Fail Rev; 2016 Sep; 21(5):539-47. PubMed ID: 27206576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging Concepts in the Molecular Basis of Pulmonary Arterial Hypertension: Part II: Neurohormonal Signaling Contributes to the Pulmonary Vascular and Right Ventricular Pathophenotype of Pulmonary Arterial Hypertension.
    Maron BA; Leopold JA
    Circulation; 2015 Jun; 131(23):2079-91. PubMed ID: 26056345
    [No Abstract]   [Full Text] [Related]  

  • 4. Current concepts of neurohormonal activation in heart failure: mediators and mechanisms.
    Lee CS; Tkacs NC
    AACN Adv Crit Care; 2008; 19(4):364-85; quiz 386-7. PubMed ID: 18981739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The sympathetic nervous system and ischaemic heart disease.
    Remme WJ
    Eur Heart J; 1998 Jun; 19 Suppl F():F62-71. PubMed ID: 9651738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications.
    Triposkiadis F; Karayannis G; Giamouzis G; Skoularigis J; Louridas G; Butler J
    J Am Coll Cardiol; 2009 Nov; 54(19):1747-62. PubMed ID: 19874988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neuro-hormonal mechanisms in heart insufficiency--from physiopathology to treatment].
    Cerqueira-Gomes M; Polónia J; Brandão F; Ramalhão C; de Faria DB
    Rev Port Cardiol; 1989 Feb; 8(2):129-48. PubMed ID: 2576635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time and technology will tell: the pathophysiologic basis of neurohormonal modulation in heart failure.
    Reed BN; Street SE; Jensen BC
    Heart Fail Clin; 2014 Oct; 10(4):543-57. PubMed ID: 25217430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurohormonal activation in canine degenerative mitral valve disease: implications on pathophysiology and treatment.
    Oyama MA
    J Small Anim Pract; 2009 Sep; 50 Suppl 1():3-11. PubMed ID: 19765215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of neurohormonal activation in chronic congestive heart failure: pathophysiology and therapeutic implications.
    Dávila DF; Núñez TJ; Odreman R; de Dávila CA
    Int J Cardiol; 2005 Jun; 101(3):343-6. PubMed ID: 15907399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neurohormonal compensation processes in chronic heart failure: the effect of drugs].
    van Zwieten PA; Lie KI
    Ned Tijdschr Geneeskd; 1994 Jun; 138(24):1208-13. PubMed ID: 7912411
    [No Abstract]   [Full Text] [Related]  

  • 12. Renal mechanisms of angiotensin II-induced hypertension.
    Granger JP; Schnackenberg CG
    Semin Nephrol; 2000 Sep; 20(5):417-25. PubMed ID: 11022893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologic management of heart failure: neurohormonal agents.
    Moser DK
    Crit Care Nurs Clin North Am; 1993 Dec; 5(4):599-608. PubMed ID: 7905275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autonomic nervous system involvement in pulmonary arterial hypertension.
    Vaillancourt M; Chia P; Sarji S; Nguyen J; Hoftman N; Ruffenach G; Eghbali M; Mahajan A; Umar S
    Respir Res; 2017 Dec; 18(1):201. PubMed ID: 29202826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The humoral regulatory systems in thromboembolism of the pulmonary arteries].
    Makarova LD; Sergeeva NA; Chirkova LD; Matiushenko AA; Savvina SIu
    Grudn Khir; 1989; (5):30-4. PubMed ID: 2574133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The renin-angiotensin system: importance in physiology and pathology.
    Ferrario CM
    J Cardiovasc Pharmacol; 1990; 15 Suppl 3():S1-5. PubMed ID: 1691411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurohormonal activation in congestive heart failure and the role of vasopressin.
    Chatterjee K
    Am J Cardiol; 2005 May; 95(9A):8B-13B. PubMed ID: 15847852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of neurohormonal antagonism on symptoms and quality-of-life in heart failure.
    Metra M; Nodari S; D'Aloia A; Madureri A; Rosselli F; Bontempi L; Zanini R; Dei Cas L
    Eur Heart J; 1998 Feb; 19 Suppl B():B25-35. PubMed ID: 9519349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological mechanism of angiotensin II receptor antagonists: implications for the treatment of elevated systolic blood pressure.
    Brooks DP; Ruffolo RR
    J Hypertens Suppl; 1999 Jun; 17(2):S27-32. PubMed ID: 10465064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for the survival benefit of neurohormonal antagonists in the management of geriatric congestive heart failure.
    Firdaus M; Bukhari N
    J Okla State Med Assoc; 2003 Mar; 96(3):133-9. PubMed ID: 12688226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.